Santos da Silva Jorge 4

4 · MoonLake Immunotherapeutics · Filed Apr 14, 2026

AI-generated summary of this filing

Updated Apr 14, 2026

MoonLake (MLTX) CEO Santos da Silva Jorge Sells Shares

What Happened

Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics (MLTX), sold a total of 150,000 shares in open-market transactions.
He disposed of 98,127 shares on 2026-04-10 at a weighted-average price of $18.41 for proceeds of $1,806,518, and 51,873 shares on 2026-04-13 at a weighted-average price of $18.23 for proceeds of $945,645, totaling $2,752,163.
This was a sale (not a purchase); such sales are often routine and do not necessarily indicate company prospects.

Key Details

Transaction dates and prices:
- 2026-04-10: 98,127 shares sold @ $18.41 (weighted avg); reported price range $18.00–$19.55 (see footnote F2).
- 2026-04-13: 51,873 shares sold @ $18.23 (weighted avg); reported price range $18.00–$18.41 (see footnote F3).
Sales were made pursuant to Rule 144 under the Securities Act (footnote F1).
The weighted-average prices reflect multiple trades; the filer will provide a per-price breakdown to the SEC or issuer upon request (F2, F3).
Shares owned after the transactions are not specified in the information provided.
Filing status: Form 4 was filed on 2026-04-14 and appears timely for the reported trade dates (not indicated as late).

Context

These are open-market sales of already-held shares (no option exercises or awards reported). Sales by executives can be for many personal or tax reasons; they are factual disclosures rather than commentary on company fundamentals.

Form 4

Period: 2026-04-10

DirectorChief Executive Officer

Transactions

Sale
Class A ordinary shares, par value $0.0001 per share
[F2][F1]
2026-04-10$18.41/sh−98,127$1,806,518→ 2,976,766 total
Sale
Class A ordinary shares, par value $0.0001 per share
[F3][F1]
2026-04-13$18.23/sh−51,873$945,645→ 2,924,893 total

Footnotes (3)

[F1]Sales made pursuant to Rule 144 under the Securities Act of 1933, as amended.
[F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $18.00 to $19.55. Upon request by the staff of the U.S. Securities and Exchange Commission (the "SEC"), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
[F3]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.41. Upon request by the staff of the SEC, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Signature

/s/ Matthias Bodenstedt, Attorney-in-fact for Jorge Santos da Silva|2026-04-14

1 file